Benjamin I Bearnot MD MPH (He/Him)
Addiction Medicine
Primary Care, Middlebury Family Health
Join to View Full Profile
Middlebury Family Health1330 Exchange St, Suite 201Middlebury, VT 05753
Phone+1 802-388-1500
Dr. Bearnot is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Benjamin Bearnot is an internal medicine specialist with a subspecialty in addiction medicine, currently practicing as a primary care physician at Middlebury Family Health in Middlebury, VT. He completed his medical education at New York University School of Medicine and his residency in internal medicine at Massachusetts General Hospital. Dr. Bearnot has held positions at Massachusetts General Hospital and Massachusetts General Physicians Organization. His research focuses on opioid use disorder and related treatments, with publications in several reputable journals, including International Journal of Mental Health and Addiction, JAMA Health Forum, and Science Advances.
Education & Training
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2016
New York University School of MedicineClass of 2013
Certifications & Licensure
VT State Medical License 2023 - 2026
MA State Medical License 2016 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- Percutaneous Mechanical Aspiration for Infective Endocarditis: Proceedings From an Inaugural Multidisciplinary Summit and Comprehensive Review.Lucas X Marinacci, Sanjum S Sethi, Molly L Paras, Abdallah El Sabbagh, Eric A Secemsky
Journal of the Society for Cardiovascular Angiography & Interventions. 2024-12-01 - 12 citationsImpact of Alternative Ways to Operationalize Buprenorphine Treatment Duration on Understanding Continuity of Care for Opioid Use Disorder.Huiru Dong, Erin J Stringfellow, W Alton Russell, Benjamin Bearnot, Mohammad S Jalali
International Journal of Mental Health and Addiction. 2024-08-01 - 7 citationsCost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids.Anneke L Claypool, Catherine DiGennaro, W Alton Russell, Melike F Yildirim, Alan F Zhang
JAMA Health Forum. 2023-05-05
Press Mentions
- Access to Treatment for Drug Use Disorders at US Health Centers: A National StudyMay 14th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
